An Observational Study of Continuous TKI258, in Castration-Resistant Prostate Cancer Patients Evaluating Markers of FGF Signaling in Bone Marrow Plasma
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Dovitinib (Primary)
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- 15 Jun 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 12 Apr 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Apr 2019.